Mitsuo Sawai
Directeur Général chez SAWAI GROUP HOLDINGS CO., LTD.
Fortune : 40 M $ au 30/04/2024
Postes actifs de Mitsuo Sawai
Sociétés | Poste | Début | Fin |
---|---|---|---|
SAWAI GROUP HOLDINGS CO., LTD. | Directeur Général | 01/04/2021 | - |
Président | 01/04/2021 | - | |
Sawai Pharmaceutical Co., Ltd.
Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Président | 23/06/2020 | - |
Directeur/Membre du Conseil | 01/06/2000 | 23/06/2020 | |
President | 01/06/2008 | 23/06/2020 | |
Sales & Marketing | 01/06/2000 | 01/06/2008 |
Historique de carrière de Mitsuo Sawai
Statistiques
Internationale
Japon | 3 |
Opérationnelle
Chairman | 2 |
Director/Board Member | 1 |
President | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
SAWAI GROUP HOLDINGS CO., LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
Sawai Pharmaceutical Co., Ltd.
Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Health Technology |
- Bourse
- Insiders
- Mitsuo Sawai
- Expérience